Moreover, since upregulation of PLAU levels is also frequently observed in a number of malignancies and upregulation of PLAU is a prognostic marker not only in pancreatic cancer but also in head and neck, endometrial cancer, renal and lung (42), breast (140) and oesophageal cancer (27). Here, PLAU is linked to familial pancreatic carcinoma.